Chronic Kidney Disease Improvement in Research and Treatment Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 23, 2019)
Chronic Kidney Disease Improvement in Research and Treatment Act
This bill expands, establishes, and otherwise modifies requirements under Medicare and other health care programs relating to individuals with end-stage renal disease (ESRD).
Among other things, the bill
- expands the scope of the National Health Service Corps to specifically include kidney disease specialists,
- modifies payments under the Medicare ESRD program to exclude certain adjustment factors (e.g., comorbidities),
- authorizes incentive payments for renal dialysis facilities that exceed performance standards under the Medicare ESRD program, and
- expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies) to all ESRD beneficiaries.
What just happenedJul 24, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 23, 2019
- Jul 24, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 23, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 23, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 23, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 23, 2019IntroReferralIntro-H
Introduced in House
- Jul 23, 2019IntroReferral1000
Introduced in House